Identification of lamin A/C ( LMNA) gene mutations in Korean patients with autosomal dominant Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy 1B - PubMed

Case Reports

Identification of lamin A/C ( LMNA) gene mutations in Korean patients with autosomal dominant Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy 1B

Chang-Seok Ki et al. J Hum Genet. 2002.

Abstract

Mutations in the LMNA gene encoding lamins A and C by alternative splicing have been found to cause at least four different kinds of genetic disorders: autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD2; MIM 181350); limb-girdle muscular dystrophy type 1B (LGMD1B; MIM 159001); dilated cardiomyopathy type 1A (CMD1A; MIM 115200); and familial partial lipodystrophy (FPLD; MIM 151660). Recently, we have studied two Korean patients with atrioventricular conduction defects. They had variable extents of muscular dystrophy; one patient was diagnosed with EDMD2 and the other with LGMD1B. We performed a mutation analysis of the LMNA gene by direct sequencing and found two different missense mutations: R249Q and R377L, in the EDMD2 and LGMD1B patient, respectively. The R249Q mutation is located within the central rod domain of the LMNA gene, and has been described in at least five unrelated sporadic EDMD2 patients. On the other hand, the R377L mutation, also located within the rod domain, is a novel mutation, although a histidine substitution instead of leucine (R377H) has been reported previously in an LGMD1B patient. To our knowledge, this is the first report of LMNA gene mutations in Korean patients with EDMD2 and LGMD1B.

Similar articles

• Mutations in the LMNA gene encoding lamin A/C.

  Genschel J, Schmidt HH. Genschel J, et al. Hum Mutat. 2000 Dec;16(6):451-9. doi: 10.1002/1098-1004(200012)16:6<451::AID-HUMU1>3.0.CO;2-9. Hum Mutat. 2000. PMID: 11102973 Review.

• Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B).

  Muchir A, Bonne G, van der Kooi AJ, van Meegen M, Baas F, Bolhuis PA, de Visser M, Schwartz K. Muchir A, et al. Hum Mol Genet. 2000 May 22;9(9):1453-9. doi: 10.1093/hmg/9.9.1453. Hum Mol Genet. 2000. PMID: 10814726

• Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene.

  Bonne G, Mercuri E, Muchir A, Urtizberea A, Bécane HM, Recan D, Merlini L, Wehnert M, Boor R, Reuner U, Vorgerd M, Wicklein EM, Eymard B, Duboc D, Penisson-Besnier I, Cuisset JM, Ferrer X, Desguerre I, Lacombe D, Bushby K, Pollitt C, Toniolo D, Fardeau M, Schwartz K, Muntoni F. Bonne G, et al. Ann Neurol. 2000 Aug;48(2):170-80. Ann Neurol. 2000. PMID: 10939567

• Novel and recurrent mutations in lamin A/C in patients with Emery-Dreifuss muscular dystrophy.

  Brown CA, Lanning RW, McKinney KQ, Salvino AR, Cherniske E, Crowe CA, Darras BT, Gominak S, Greenberg CR, Grosmann C, Heydemann P, Mendell JR, Pober BR, Sasaki T, Shapiro F, Simpson DA, Suchowersky O, Spence JE. Brown CA, et al. Am J Med Genet. 2001 Sep 1;102(4):359-67. doi: 10.1002/ajmg.1463. Am J Med Genet. 2001. PMID: 11503164

• The A-type lamins: nuclear structural proteins as a focus for muscular dystrophy and cardiovascular diseases.

  Mounkes LC, Burke B, Stewart CL. Mounkes LC, et al. Trends Cardiovasc Med. 2001 Oct;11(7):280-5. doi: 10.1016/s1050-1738(01)00126-8. Trends Cardiovasc Med. 2001. PMID: 11709282 Review.

Cited by

• Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption.

  Gupta P, Bilinska ZT, Sylvius N, Boudreau E, Veinot JP, Labib S, Bolongo PM, Hamza A, Jackson T, Ploski R, Walski M, Grzybowski J, Walczak E, Religa G, Fidzianska A, Tesson F. Gupta P, et al. Basic Res Cardiol. 2010 May;105(3):365-77. doi: 10.1007/s00395-010-0085-4. Epub 2010 Feb 3. Basic Res Cardiol. 2010. PMID: 20127487 Free PMC article.

• Intermediate filaments: primary determinants of cell architecture and plasticity.

  Herrmann H, Strelkov SV, Burkhard P, Aebi U. Herrmann H, et al. J Clin Invest. 2009 Jul;119(7):1772-83. doi: 10.1172/JCI38214. Epub 2009 Jul 1. J Clin Invest. 2009. PMID: 19587452 Free PMC article. Review.

• Myofiber degeneration in autosomal dominant Emery-Dreifuss muscular dystrophy (AD-EDMD) (LGMD1B).

  Mittelbronn M, Hanisch F, Gleichmann M, Stötter M, Korinthenberg R, Wehnert M, Bonne G, Rudnik-Schöneborn S, Bornemann A. Mittelbronn M, et al. Brain Pathol. 2006 Oct;16(4):266-72. doi: 10.1111/j.1750-3639.2006.00028.x. Brain Pathol. 2006. PMID: 17107595 Free PMC article.

• Lamin A/C Mechanotransduction in Laminopathies.

  Donnaloja F, Carnevali F, Jacchetti E, Raimondi MT. Donnaloja F, et al. Cells. 2020 May 24;9(5):1306. doi: 10.3390/cells9051306. Cells. 2020. PMID: 32456328 Free PMC article. Review.

• RNAi-based gene therapy for dominant Limb Girdle Muscular Dystrophies.

  Liu J, Harper SQ. Liu J, et al. Curr Gene Ther. 2012 Aug;12(4):307-14. doi: 10.2174/156652312802083585. Curr Gene Ther. 2012. PMID: 22856606 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Molecular Biology Databases

  • BioCyc
  • GlyGen glycoinformatics resource

• Miscellaneous

  • NCI CPTAC Assay Portal